
Journal of Medicinal Chemistry p. 1009 - 1014 (1990)
Update date:2022-08-05
Topics:
Gamcsik, Michael P.
Hamill, Terence G.
Colvin, Michael
Many cancer cells are resistant to chemotherapeutic treatment with mechlorethamine and other alkylating agents.These drug-resistant cells often show an increase in the intracellular concentration of glutathione and an increase in the activity of glutathione-S-transferase when compared to the sensitive cells.Both of these components are thought to be involved with inactivation of the drug either through conjugation with glutathione or by hydrolysis.NMR spectroscopy was used to monitor the nonenzymatic conjugation of mechlorethamine with glutathione.Several intermediates along the pathway to the doubly glutathione substituted mustard, including both mustard-aziridinium adducts, can be observed.The assignment of the 1H NMR spectrum of these adducts are presented.At 30 deg C, pH 7.0, no hydrolyzed mustard was detectable.With the use of 13C-labeled mustard, the conjugation reaction can be shown to proceed through an aziridinium intermediate rather than by direct nucleophilic substitution.
View MoreShanghai Korey Pharm Co.,Ltd.(expird)
Contact:021-61840961 021-61840962
Address:No.157,Zhuguang Rd, Qingpu, Shanghai, China
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Dalian RSD International Trade Co.,Ltd.(expird)
Contact:86-22-60875058 58610575
Address:Wantong International Areas, Hongqiao District, Tianjin, China.China
Wuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
Doi:10.1016/j.ejmech.2010.05.062
(2010)Doi:10.1016/j.tet.2010.06.042
(2010)Doi:10.1016/j.tetasy.2010.04.023
(2010)Doi:10.1016/j.tetlet.2010.07.149
(2010)Doi:10.1021/jo00301a036
(1990)Doi:10.1016/j.tet.2010.07.032
(2010)